Eton Pharmaceuticals Inc (ETON)
Company Info
| ISIN | US29772L1089 |
|---|---|
| CUSIP | 29772L108 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Highlights
| Market Cap | $88.11M |
|---|---|
| EPS | -$0.04 |
| PE Ratio | 49.56 |
| Revenue (TTM) | $31.64M |
| Gross Profit (TTM) | $14.32M |
| EBITDA (TTM) | -$358.00K |
| Year Range | $2.42 - $5.81 |
| Target Price | $8.00 |
| Short % | 0.36% |
| Short Ratio | 1.61 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ETON vs. ACET
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Eton Pharmaceuticals Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Eton Pharmaceuticals Inc had a return of -21.69% year-to-date (YTD) and -1.15% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -21.69% | 9.47% |
| 1 month | 0.00% | 1.91% |
| 6 months | -10.68% | 18.36% |
| 1 year | -1.15% | 26.61% |
| 5 years (annualized) | -16.21% | 12.90% |
| 10 years (annualized) | N/A | 10.79% |
Monthly Returns
The table below presents the monthly returns of ETON, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 6.62% | -4.71% | -15.73% | -6.67% | -21.69% | ||||||||
| 2023 | 23.40% | 7.18% | 3.22% | -5.71% | 9.09% | -11.87% | -19.20% | 59.57% | -7.33% | 1.20% | -16.11% | 23.73% | 55.32% |
| 2022 | -13.75% | 1.62% | 15.96% | -19.04% | -13.88% | -13.82% | 2.29% | -15.67% | -7.08% | 21.43% | 18.43% | -6.62% | -34.27% |
| 2021 | 9.72% | -11.32% | -7.46% | 18.58% | -18.66% | -12.75% | -16.56% | 2.53% | -4.36% | 14.29% | -32.29% | 10.00% | -47.23% |
| 2020 | -7.50% | -18.92% | -24.07% | 26.34% | -11.20% | 18.48% | 22.57% | 17.37% | 0.77% | -7.72% | 8.92% | 2.39% | 12.92% |
| 2019 | -0.33% | 30.16% | 0.76% | -8.00% | 10.05% | -2.47% | -22.91% | -8.21% | 13.06% | -5.85% | 7.56% | 12.50% | 17.65% |
| 2018 | 1.60% | -3.62% | -2.08% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ETON is 45, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
ETON (Eton Pharmaceuticals Inc)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Eton Pharmaceuticals Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Eton Pharmaceuticals Inc was 79.94%, occurring on Oct 20, 2022. The portfolio has not yet recovered.
The current Eton Pharmaceuticals Inc drawdown is 65.94%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -79.94% | Feb 18, 2021 | 423 | Oct 20, 2022 | — | — | — |
| -67.13% | Jul 11, 2019 | 174 | Mar 18, 2020 | 128 | Sep 18, 2020 | 302 |
| -26.56% | Sep 21, 2020 | 12 | Oct 6, 2020 | 69 | Jan 14, 2021 | 81 |
| -15.38% | May 29, 2019 | 19 | Jun 24, 2019 | 11 | Jul 10, 2019 | 30 |
| -14.37% | Dec 19, 2018 | 11 | Jan 4, 2019 | 26 | Feb 12, 2019 | 37 |
Volatility
Volatility Chart
The current Eton Pharmaceuticals Inc volatility is 17.20%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |